TARO CZ ER 200 TARO CZ ER 200 Pill - green & white capsule/oblong, 20mm
Pill with imprint TARO CZ ER 200 TARO CZ ER 200 is Green & White, Capsule/Oblong and has been identified as Carbamazepine Extended-Release 200 mg. It is supplied by Taro Pharmaceuticals U.S.A., Inc.
Carbamazepine is used in the treatment of Trigeminal Neuralgia; Bipolar Disorder; Schizoaffective Disorder; Epilepsy; Seizures and belongs to the drug class dibenzazepine anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Carbamazepine 200 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for TARO CZ ER 200 TARO CZ ER 200
Carbamazepine Extended-Release
- Imprint
- TARO CZ ER 200 TARO CZ ER 200
- Strength
- 200 mg
- Color
- Green & White
- Size
- 20.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Dibenzazepine anticonvulsants
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Taro Pharmaceuticals U.S.A., Inc.
- National Drug Code (NDC)
- 51672-4150
- Inactive Ingredients
-
silicon dioxide,
magnesium stearate,
microcrystalline cellulose,
triethyl citrate,
FD&C Blue No. 1,
gelatin,
ferric oxide yellow,
sodium lauryl sulfate,
titanium dioxide,
sodium starch glycolate type A potato,
ammonio methacrylate copolymer type A
Note: Inactive ingredients may vary.
More about carbamazepine
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (350)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Drug class: dibenzazepine anticonvulsants
- Breastfeeding
- En español
Patient resources
Other brands
Tegretol, Tegretol XR, Carbatrol, Epitol, ... +2 more
Professional resources
- Carbamazepine monograph
- Carbamazepine (FDA)
- Carbamazepine Capsules (FDA)
- Carbamazepine Chewable (FDA)
- Carbamazepine ER (FDA)
- Carbamazepine Oral Suspension (FDA)
Other brands
Tegretol, Carbatrol, Epitol, Equetro, Carnexiv
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.